Valentino Racki

Rijeka, 51000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

The Kidney-Brain Axis in Chronic Kidney Disease: Uremic Toxins, Cognitive Decline, Mechanistic Pathways, Biomarkers and Therapeutic Perspectives.

The Kidney-Brain Axis in Chronic Kidney Disease: Uremic Toxins, Cognitive Decline, Mechanistic Pathways, Biomarkers and Therapeutic Perspectives.

Journal: Biomedicines

Published: May 15, 2026

Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.

Deprescribing and Anti-CGRP preventive therapy in medication-overuse headache associated with migraine: pathophysiological rationale and single-center real world evidence.

Journal: Frontiers in drug safety and regulation

Published: March 22, 2026

Nanotube-Assisted Motor Neuron and Neuromuscular Junction Stabilization in Spinal Muscular Atrophy: A Hypothesis for Adjunctive Therapy.

Nanotube-Assisted Motor Neuron and Neuromuscular Junction Stabilization in Spinal Muscular Atrophy: A Hypothesis for Adjunctive Therapy.

Journal: Neurology international

Published: March 02, 2026

Enrichment of Rare Variants in Nuclear-Encoded Mitochondrial Metabolism Genes in Patients with Early-Onset or Familial Parkinson's Disease.

Enrichment of Rare Variants in Nuclear-Encoded Mitochondrial Metabolism Genes in Patients with Early-Onset or Familial Parkinson's Disease.

Journal: Genes

Published: February 28, 2026

Clinical Utility of GBA Genotyping Prior to Deep Brain Stimulation: A Narrative Review.

Clinical Utility of GBA Genotyping Prior to Deep Brain Stimulation: A Narrative Review.

Journal: Genes

Published: December 05, 2025

Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy.

Novel Translational Concept: Axon-to-Muscle Exosomal Signaling as an Emerging Therapeutic Target in Spinal Muscular Atrophy.

Journal: Biomedicines

Published: October 21, 2025

Biallelic RFC1 Expansions Are a Rare Cause of Early-Onset and Familial Parkinson's Disease.

Biallelic RFC1 Expansions Are a Rare Cause of Early-Onset and Familial Parkinson's Disease.

Journal: Clinical genetics

Published: September 09, 2025

Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer's Disease.

Clinical Significance of APOE4 Genotyping: Potential for Personalized Therapy and Early Diagnosis of Alzheimer's Disease.

Journal: Journal of clinical medicine

Published: July 30, 2025

Does the effectiveness of neuraxial morphine administration vary across different patient populations, dosing strategies, and delivery techniques?

Does the effectiveness of neuraxial morphine administration vary across different patient populations, dosing strategies, and delivery techniques?

Journal: Croatian medical journal

Published: July 10, 2025

Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2.

Transforming Spinal Muscular Atrophy: From Pivotal Trials to Real-World Evidence and Future Therapeutic Frontiers in Types 1 and 2.

Journal: Biomedicines

Published: June 24, 2025

Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy.

Prenatal Management of Spinal Muscular Atrophy in the Era of Genetic Screening and Emerging Opportunities in In Utero Therapy.

Journal: Biomedicines

Published: June 15, 2025

Microbial diversity in drug-naïve Parkinson's disease patients.

Microbial diversity in drug-naïve Parkinson's disease patients.

Journal: PloS one

Published: February 22, 2025

Showing 1-12 of 38

Last Updated: 09/26/2026